Viewing Study NCT06012734


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-05-26 @ 12:06 PM
Study NCT ID: NCT06012734
Status: RECRUITING
Last Update Posted: 2024-08-30
First Post: 2023-07-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients
Sponsor:
Organization: